Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annick Alperovitch

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Medecine Sciences : M/S|May 2, 2020
[Ethics of clinical trials]Annick Alperovitch, Philippe Lazar
Stroke|February 3, 2007
The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city studyJean-Philippe Empana, Mahmoud Zureik, Jerome Gariepy, et al.
European Journal of Epidemiology|June 13, 2013
20-Year prevalence projections for dementia and impact of preventive policy about risk factorsHélène Jacqmin-Gadda, Annick Alperovitch, Claire Montlahuc, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2013
Reply: To PMID 22664163Paul Michel Mertes, Pascal Demoly, Annick Alperovitch, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2012
Methylene blue-treated plasma: an increased allergy risk?Paul Michel Mertes, Pascal Demoly, Annick Alperovitch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2013
Intensity of human prion disease surveillance predicts observed disease incidenceGenevieve M J A Klug, Handan Wand, Marion Simpson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Medecine Sciences : M/S|May 2, 2020
[Ethics of clinical trials]Annick Alperovitch, Philippe Lazar
Stroke|February 3, 2007
The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city studyJean-Philippe Empana, Mahmoud Zureik, Jerome Gariepy, et al.
European Journal of Epidemiology|June 13, 2013
20-Year prevalence projections for dementia and impact of preventive policy about risk factorsHélène Jacqmin-Gadda, Annick Alperovitch, Claire Montlahuc, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2013
Reply: To PMID 22664163Paul Michel Mertes, Pascal Demoly, Annick Alperovitch, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2012
Methylene blue-treated plasma: an increased allergy risk?Paul Michel Mertes, Pascal Demoly, Annick Alperovitch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2013
Intensity of human prion disease surveillance predicts observed disease incidenceGenevieve M J A Klug, Handan Wand, Marion Simpson, et al.
Pageof 1